CFRA analyst Sam Stovall upgrades EOG Resources (NYSE:EOG) from Market Weight to Overweight.
SVB Leerink Maintains Market Perform on Alnylam Pharmaceuticals, Raises Price Target to $145
SVB Leerink analyst Mani Foroohar maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $142 to $145.